ARCHIVES

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

May 25, 2001

In Brief: Sartorelli AACI President, McInTyre President Elect; Moertel to Receive ACCC Clinical Award

July 10, 1987

Wilms’ Tumor Survivors At High Risk Of Heart Failure

April 27, 2001

Also in this 8-page issue: NCI, FDA open Web site for adverse event reporting.

April 16, 2004

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987

NSABP Executive Committee Joins Fisher In Suit Against Pitt

August 5, 1994